That's a wrap.
Market opens Friday, Nov 13 at 9:30 AM ET
8:30 AMYahoo Finance
Ultragenyx to Participate at investor Conferences in London
3:30 AMYahoo Finance
Ultragenyx announces the marketing authorisation application (MAA) for its Investigational Gene Therapy for MPS IIIA (Sanfilippo syndrome Type a) is under Review with the UK Medicines and Healthcare Products Regulatory Agency (MHRA)
9:14 PMYahoo Finance
What Ultragenyx Pharmaceutical (RARE) said on its Q3 earnings call
4:05 PMYahoo Finance
Ultragenyx to Host Conference call for third quarter 2026 Financial results and Corporate update